Skip to main content
OpenTrials
Completed

NCT Number: NCT06156787

Patterns of Urinary Bladder Cancer in Darfur, Suda

Background: Bladder cancer (BC) exhibits extreme heterogeneity regarding clinical outcome, etiology, histology, and geographic distribution. Recent clinical observations point to alterations in the BC pattern in the Sudan, possibly as a result of lifestyle changes brought on by the enormous migration from rural to urban locations. This study aimed to identify the pattern of bladder cancer in Darfur.

Patients and Methods: A cross sectional, hospital-based study, it was conducted inNyala specialized hospital, during the period from (2020 to 2022), included one hundred and five patients with bladder mass matching the inclusion criteria were studied over the diversity of demographic data , clinical finding, pathological type and possible risk factors .

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All Sudanese pts who lives in Darfur and presented with urinary bladder mass.
  • Adult above 18 years

Exclusion criteria

  • Patient who does not live in Darfur.
  • Patients refused to participate in the study.

Treatment and study plan

Primary outcomes

  1. Patterns of Urinary Bladder Cancer in Darfur, Sudan

    Time frame: The research is a cross-sectional, hospital-based study conducted at Nyala Specialized Hospital in Darfur. The study spans a period from 2020 to 2022.

    This research study investigates the patterns of urinary bladder cancer (BC) in Darfur, Sudan, with a focus on understanding the clinical outcomes, etiology, histology, and demographic distribution of the disease.

Sponsors and collaborators

Lead sponsor

National Center for Gastroentestinal and Liver Disease

Other

Registry information

Official study title

Patterns of Urinary Bladder Cancer in Darfur, Sudan 2020 - 2022

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Dec 5, 2023
Registry last updated
Dec 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.